563 related articles for article (PubMed ID: 12627330)
1. Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha.
Pruhova S; Ek J; Lebl J; Sumnik Z; Saudek F; Andel M; Pedersen O; Hansen T
Diabetologia; 2003 Feb; 46(2):291-5. PubMed ID: 12627330
[TBL] [Abstract][Full Text] [Related]
2. Nine novel mutations in maturity-onset diabetes of the young (MODY) candidate genes in 22 Spanish families.
Barrio R; Bellanné-Chantelot C; Moreno JC; Morel V; Calle H; Alonso M; Mustieles C
J Clin Endocrinol Metab; 2002 Jun; 87(6):2532-9. PubMed ID: 12050210
[TBL] [Abstract][Full Text] [Related]
3. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes.
Chèvre JC; Hani EH; Boutin P; Vaxillaire M; Blanché H; Vionnet N; Pardini VC; Timsit J; Larger E; Charpentier G; Beckers D; Maes M; Bellanné-Chantelot C; Velho G; Froguel P
Diabetologia; 1998 Sep; 41(9):1017-23. PubMed ID: 9754819
[TBL] [Abstract][Full Text] [Related]
4. High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes.
Lehto M; Wipemo C; Ivarsson SA; Lindgren C; Lipsanen-Nyman M; Weng J; Wibell L; Widén E; Tuomi T; Groop L
Diabetologia; 1999 Sep; 42(9):1131-7. PubMed ID: 10447526
[TBL] [Abstract][Full Text] [Related]
5. Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.
Estalella I; Rica I; Perez de Nanclares G; Bilbao JR; Vazquez JA; San Pedro JI; Busturia MA; Castaño L;
Clin Endocrinol (Oxf); 2007 Oct; 67(4):538-46. PubMed ID: 17573900
[TBL] [Abstract][Full Text] [Related]
6. Half of clinically defined maturity-onset diabetes of the young patients in Denmark do not have mutations in HNF4A, GCK, and TCF1.
Johansen A; Ek J; Mortensen HB; Pedersen O; Hansen T
J Clin Endocrinol Metab; 2005 Aug; 90(8):4607-14. PubMed ID: 15928245
[TBL] [Abstract][Full Text] [Related]
7. Genetic and clinical characterisation of maturity-onset diabetes of the young in Spanish families.
Costa A; Bescós M; Velho G; Chêvre J; Vidal J; Sesmilo G; Bellanné-Chantelot C; Froguel P; Casamitjana R; Rivera-Fillat F; Gomis R; Conget I
Eur J Endocrinol; 2000 Apr; 142(4):380-6. PubMed ID: 10754480
[TBL] [Abstract][Full Text] [Related]
8. Genetic and clinical characteristics of maturity-onset diabetes of the young in Chinese patients.
Xu JY; Dan QH; Chan V; Wat NM; Tam S; Tiu SC; Lee KF; Siu SC; Tsang MW; Fung LM; Chan KW; Lam KS
Eur J Hum Genet; 2005 Apr; 13(4):422-7. PubMed ID: 15657605
[TBL] [Abstract][Full Text] [Related]
9. A novel Phe75fsdelT mutation in the hepatocyte nuclear factor-4alpha gene in a Danish pedigree with maturity-onset diabetes of the young.
Møller AM; Dalgaard LT; Ambye L; Hansen L; Schmitz O; Hansen T; Pedersen O
J Clin Endocrinol Metab; 1999 Jan; 84(1):367-9. PubMed ID: 9920109
[TBL] [Abstract][Full Text] [Related]
10. beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.
Frayling TM; Evans JC; Bulman MP; Pearson E; Allen L; Owen K; Bingham C; Hannemann M; Shepherd M; Ellard S; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S94-100. PubMed ID: 11272211
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the genes for hepatocyte nuclear factor (HNF)-1alpha, -4alpha, -1beta, and -3beta; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians.
Baier LJ; Permana PA; Traurig M; Dobberfuhl A; Wiedrich C; Sutherland J; Thuillez P; Luczy-Bachman G; Hara M; Horikawa Y; Hinokio Y; Hanson RL; Bogardus C
Diabetes Care; 2000 Mar; 23(3):302-4. PubMed ID: 10868855
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1).
Yamagata K; Furuta H; Oda N; Kaisaki PJ; Menzel S; Cox NJ; Fajans SS; Signorini S; Stoffel M; Bell GI
Nature; 1996 Dec; 384(6608):458-60. PubMed ID: 8945471
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection.
Pearson ER; Pruhova S; Tack CJ; Johansen A; Castleden HA; Lumb PJ; Wierzbicki AS; Clark PM; Lebl J; Pedersen O; Ellard S; Hansen T; Hattersley AT
Diabetologia; 2005 May; 48(5):878-85. PubMed ID: 15830177
[TBL] [Abstract][Full Text] [Related]
14. Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene.
Lindner T; Gragnoli C; Furuta H; Cockburn BN; Petzold C; Rietzsch H; Weiss U; Schulze J; Bell GI
J Clin Invest; 1997 Sep; 100(6):1400-5. PubMed ID: 9294105
[TBL] [Abstract][Full Text] [Related]
15. Genetic evidence that HNF-1alpha-dependent transcriptional control of HNF-4alpha is essential for human pancreatic beta cell function.
Hansen SK; Párrizas M; Jensen ML; Pruhova S; Ek J; Boj SF; Johansen A; Maestro MA; Rivera F; Eiberg H; Andel M; Lebl J; Pedersen O; Ferrer J; Hansen T
J Clin Invest; 2002 Sep; 110(6):827-33. PubMed ID: 12235114
[TBL] [Abstract][Full Text] [Related]
16. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients.
Hwang JS; Shin CH; Yang SW; Jung SY; Huh N
Diabetes Res Clin Pract; 2006 Oct; 74(1):75-81. PubMed ID: 16632067
[TBL] [Abstract][Full Text] [Related]
17. Genetic, metabolic and clinical characteristics of maturity onset diabetes of the young.
Velho G; Froguel P
Eur J Endocrinol; 1998 Mar; 138(3):233-9. PubMed ID: 9539292
[TBL] [Abstract][Full Text] [Related]
18. Routine mutation screening of HNF-1alpha and GCK genes in MODY diagnosis: how effective are the techniques of DHPLC and direct sequencing used in combination?
Boutin P; Vasseur F; Samson C; Wahl C; Froguel P
Diabetologia; 2001 Jun; 44(6):775-8. PubMed ID: 11440371
[TBL] [Abstract][Full Text] [Related]
19. Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
Stride A; Hattersley AT
Ann Med; 2002; 34(3):207-16. PubMed ID: 12173691
[TBL] [Abstract][Full Text] [Related]
20. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
